Link copied
Lilly Approves $15 Billion in Share Buybacks, Raises Dividend
stock :: 2024-12-10 :: source - bloomberg
By John Lauerman
(Bloomberg) -- Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by the blockbuster weight-loss drug Zepbound.
Most Read from Bloomberg
A Chicago Skyscraper Cements the Legacy of a Visionary Postmodern Architect
Cloud Computing Tax Threatens Chicago’s Silicon Valley Ambitions
NYC’s Run-Down Bus Terminal Gets Approval for $10 Billion Revamp
Kansas City Looks Back on its Long, Costly Ride With Microtransit
The company also raised its quarterly dividend 15%, according to a statement Monday. The shares rose as much as 1.3% in late trading after the US markets closed.
The share repurchases may be made from time to time at management’s discretion, Lilly said.
Most Read from Bloomberg Businessweek
This week top market trends.
-
Jefferies Predicts Up to 1000% Surge for These 2 'Strong Buy' Stocks
2024-12-09 :: investing ideas :: tipranks -
Alphabet Ends 2024 on High With Help From Quantum Tech Leap
2024-12-19 :: stock :: bloomberg -
SK Hynix Hikes Dividend Payout to $2.1 Billion as AI Lead Widens
2024-11-27 :: stock :: bloomberg -
Trip.com Rises on Strong Demand, Big Money
2024-12-21 :: stock :: fx empire -
US Nov payrolls show job growth accelerated after October hiccup
2024-12-06 :: general :: reuters
Recent global market news
-
Holiday Stock Sale: 3 Top High-Yield Dividend Stocks to Buy After the Recent Dip
10hrs ago :: :: motley fool -
Arthur Hayes predicts crypto will see 'harrowing dump' around Trump's inauguration
2024-12-18 :: :: theblock
